| RS2546047421 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546048023 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546048314 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546048657 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546048772 |
MFSD8
|
Health Risk |
Likely pathogenic |
— |
| RS2546049717 |
TAFAZZIN
|
Health Risk |
Likely pathogenic |
3-Methylglutaconic aciduria type 2, 3-Methylglutaconic aciduria type 2 |
| RS2546060637 |
GMPPA
|
Health Risk |
Pathogenic |
Alacrima, achalasia |
| RS2546061147 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2546061360 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2546061617 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546061717 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546073737 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546074464 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546074494 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546074624 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546074630 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546074803 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546074880 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546075164 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546075201 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546075268 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546075295 |
TRIM37
|
Health Risk |
Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2546075421 |
TRIM37
|
Health Risk |
Pathogenic/Likely pathogenic |
Mulibrey nanism syndrome, Mulibrey nanism syndrome |
| RS2546076304 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546076440 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2546076865 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2546077425 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS2546077768 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546077811 |
ACOX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitchell syndrome, Acyl-CoA oxidase deficiency |
| RS2546077877 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546079404 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546079619 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546079926 |
ACOX1
|
Health Risk |
Likely pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546079927 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546081500 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546083094 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546083130 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546083325 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546083492 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546083545 |
LPIN1
|
Health Risk |
Likely pathogenic |
— |
| RS2546083610 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546083691 |
ACOX1
|
Health Risk |
Likely pathogenic |
Mitchell syndrome, Mitchell syndrome |
| RS2546084011 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546093466 |
TRIM37
|
Health Risk |
Likely pathogenic |
— |
| RS2546093861 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546093863 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2546094359 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546094362 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546094969 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2546095844 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS2546096706 |
TPO
|
Health Risk |
Likely pathogenic |
TPO-related disorder, TPO-related disorder |
| RS2546096906 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546097846 |
ACOX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA oxidase deficiency, Mitchell syndrome |
| RS2546097855 |
ACOX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Acyl-CoA oxidase deficiency, Mitchell syndrome |
| RS2546097920 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546097956 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546098054 |
ACOX1
|
Health Risk |
Pathogenic |
Acyl-CoA oxidase deficiency, Acyl-CoA oxidase deficiency |
| RS2546099543 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS2546099890 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546101657 |
PRKG2
|
Health Risk |
Likely pathogenic |
Acromesomelic dysplasia 4, Acromesomelic dysplasia 4 |
| RS2546110253 |
AFF3
|
Health Risk |
Likely pathogenic |
KINSSHIP syndrome, KINSSHIP syndrome |
| RS2546125695 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546126494 |
TTC8
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 8, Bardet-Biedl syndrome 8 |
| RS2546126719 |
TTC8
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS2546126754 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Distal myopathy with anterior tibial onset |
| RS2546127049 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546127084 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546127240 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546127671 |
MFSD8
|
Health Risk |
Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546129963 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546130708 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546137643 |
MFSD8
|
Health Risk |
Pathogenic |
Macular dystrophy with central cone involvement, Macular dystrophy with central cone involvement |
| RS2546138613 |
MFSD8
|
Health Risk |
Pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546143605 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2546143756 |
DYSF
|
Health Risk |
Pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS2546143809 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Distal myopathy with anterior tibial onset |
| RS2546143826 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS2546144322 |
DYSF
|
Health Risk |
Likely pathogenic |
Miyoshi muscular dystrophy 1, Miyoshi muscular dystrophy 1 |
| RS2546148822 |
TRIM37
|
Health Risk |
Pathogenic |
— |
| RS2546150757 |
TSEN54
|
Health Risk |
Likely pathogenic |
— |
| RS2546151070 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546151806 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546151816 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546153020 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS2546154073 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546154115 |
TSEN54
|
Health Risk |
Likely pathogenic |
— |
| RS2546156325 |
TSEN54
|
Health Risk |
Likely pathogenic |
Pontoneocerebellar hypoplasia, Pontoneocerebellar hypoplasia |
| RS2546156411 |
TSEN54
|
Health Risk |
Likely pathogenic |
— |
| RS2546156657 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546156736 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546156895 |
TSEN54
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 4, Pontocerebellar hypoplasia type 4 |
| RS2546156923 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546156972 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546157288 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546157518 |
TSEN54
|
Health Risk |
Pathogenic |
— |
| RS2546158894 |
TSEN54
|
Health Risk |
Likely pathogenic |
— |
| RS2546164198 |
TPO
|
Health Risk |
Likely pathogenic |
— |
| RS2546164421 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |
| RS2546164535 |
TPO
|
Health Risk |
Pathogenic |
— |
| RS2546164705 |
TTC8
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 51, Retinitis pigmentosa 51 |